Deep Neuromuscular Blockade and a Low-Residue Diet for the Surgical Field in vNOTES Hysterectomy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorFatih Sultan Mehmet Training and Research Hospital

About this trial

vNOTES (vaginal natural orifice transluminal endoscopic surgery) hysterectomy is performed entirely through the vagina, with no abdominal incision. A clear surgical view is essential, and the main obstacle to the view is bowel falling into the pelvis. This randomized trial tests whether two simple measures improve the surgical field, individually or in combination: a preoperative low-residue diet for three days, and deeper intra-operative muscle relaxation (deep neuromuscular blockade). No group receives mechanical bowel preparation.

Using a 2×2 factorial design, participants are allocated equally (1:1:1:1) to one of four groups: (1) no diet with standard relaxation; (2) diet with standard relaxation; (3) no diet with deep relaxation; (4) diet with deep relaxation (the "bundle"). The surgical field is measured objectively: during a standardized window the carbon-dioxide insufflation pressure is lowered step by step, and 2-3 blinded assessors score the field from de-identified video. The primary outcome is the lowest pressure at which the field remains adequate; a lower pressure indicates an intrinsically better field.

The trial hypothesis is an interaction - that the combination achieves an adequate field at a meaningfully lower pressure than either measure alone. The final sample size is determined from an internal pilot. Secondary outcomes include the continuous field score, the need for an additional instrument to clear the field, postoperative nausea and vomiting, and routine operative outcomes.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult women (aged 18 years or older) scheduled for hysterectomy for a benign (non-cancer) indication.

Judged suitable for the vNOTES approach by the operating surgeon.

Able to understand the study and provide written informed consent.

Disqualifiers

Suspected or known gynaecological malignancy.

Conditions expected to make the approach or the field assessment non-standard (e.g., anticipated dense pelvic adhesions or severe endometriosis, a contraindication to vNOTES, or an obliterated cul-de-sac).

Any medical reason why deep neuromuscular blockade or sugammadex would be unsafe (defined with the anaesthesia team).

Any medical reason why a low-residue diet would be unsuitable.

Trial design

Design model

Factorial

Treatments tested in this trial

  • Deep Neuromuscular Blockade (NMB)

    Drug

    Rocuronium by continuous infusion to maintain profound relaxation (no train-of-four twitches; post-tetanic count 1-2) until the end of the field measurement and surgery; reversed with sugammadex and confirmation of full recovery (train-of-four ratio ≥ 0.9) before extubation. Cross-reference to arms: Arms 3, 4

  • Standard (moderate) neuromuscular blockade

    Drug

    Rocuronium by intermittent bolus to maintain a train-of-four count of 1-2 (usual care); reversed with sugammadex and confirmation of full recovery (train-of-four ratio ≥ 0.9) before extubation. Cross-reference to arms: Arms 1, 2

  • Preoperative low-residue diet

    Other intervention

    A low-residue diet (less than 10 g dietary fibre per day) for the three days before surgery, with standardised food lists and a patient information sheet. This is a dietary measure, not a laxative; no mechanical bowel preparation is used. Cross-reference to arms: Arms 2, 4

Treatment groups

160 Participants
are divided into 4 treatment groups
Group A: Arm 1 - Control (no diet + standard neuromuscular blockade NMB)Active comparator 1 intervention
Group B: Arm 2 - Diet + standard NMBExperimental treatment 2 interventions
Group C: Arm 3 - Deep NMB (no diet)Experimental treatment 1 intervention
Group D: Arm 4 - Bundle (diet + deep NMB)Experimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Lowest CO₂ insufflation pressure at which the surgical field is adequate (blinded Transvaginal Natural Orifice Endoluminal Surgery - Objectiveisual Index: vNOTES-OVI ≥ 1)

During a standardized intra-operative window, insufflation pressure is lowered from 12 mmHg to 6 mmHg in 1 mmHg steps, with a 60-second equilibration at each step; at each step a 3-second de-identified video clip is scored by 2-3 blinded assessors with the vNOTES-OVI (0/1/2). The consensus (median) score yields, per participant, the lowest pressure at which the field is adequate (OVI ≥ 1). Lower pressure indicates a better field.

Time frame
Intra-operative (single measurement window)

Secondary outcomes

1

Continuous surgical-field score (vNOTES-OVI)

Blinded vNOTES-OVI (0/1/2) at each insufflation-pressure step, analysed as a threshold-free ordinal/continuous measure.

Time frame
Intra-operative
2

Lowest pressure at the strict threshold (vNOTES-OVI = 2)

Lowest insufflation pressure at which the field is perfectly exposed (OVI = 2), blinded scoring.

Time frame
Intra-operative
3

Requirement for a third working instrument

Whether an instrument beyond the camera and the two standard working instruments - introduced through the platform's existing channel, not a new abdominal port - was required solely to expose the field or displace bowel (yes/no per case).

Time frame
Intra-operative
4

Postoperative nausea and vomiting - complete response

Proportion of participants with no nausea AND no vomiting AND no rescue antiemetic during the first 24 hours.

Time frame
0-24 hours postoperative

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Fatih Sultan Mehmet Training and Research Hospital

Lead sponsor

Acibadem University

Sponsor institution

Kutahya City Hospital

Collaborator

Kocaeli City Hospital

Collaborator

Dr. Lutfi Kirdar Kartal Training and Research Hospital

Collaborator